Dechra Pharmaceuticals PLCDPH:LSE

1,076
23.00 / 2.18%
70.38k
7.49%
0.3259
Latest price in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jun 28 2016 13:55 BST.

Summary

As of last trade Dechra Pharmaceuticals PLC (DPH:LSE) traded at 1,076, 13.92 % below its 52-week high of 1,250, set on Apr 08, 2016.

52-week range
Today
811.00
Jun 24 2016
1,250
Apr 08 2016
Markit short selling activity
Low
Medium
High
Open1,070
Day high1,100
Day low1,064
Bid1,075
Offer1,078
Previous close1,053
Average volume224.77k
Shares outstanding92.72m
Free float89.95m
P/E (TTM)45.89
Market cap976.32m GBP
EPS (TTM)0.2295 GBP
Annual div (IAD)19.30 GBX
Annual div yield (IAD)1.83%
Div ex-dateMar 10 2016
Div pay-dateApr 06 2016
Data delayed at least 15 minutes, as of Jun 28 2016 13:55 BST.
Last IC View
The last IC recommendation on Dechra Pharmaceuticals PLC shares was Buy at 1,047 on 16 Jun 2016
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Dechra Pharmaceuticals PLC+0.09 %-7.96 %-2.18 %+7.49 %+143.25 %
FTSE 100 IDX-1.04 %-1.74 %-2.42 %-8.77 %+6.84 %
Data delayed at least 15 minutes, as of Jun 28 2016 13:55 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.